Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors

NCT03185169 is registered in ClinicalTrials.gov with Alta Bates Summit Medical Center as lead sponsor.

NCT NCT03185169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03185169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors
Lead sponsor
Alta Bates Summit Medical Center
Phase
Phase 1
Overall status
Terminated
Start date
November 18, 2016
Completion date
July 23, 2018
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, dyspareunia, dysuria, genitourinary abnormality, urinary tract infections, vaginal abnormality